211 related articles for article (PubMed ID: 36151447)
1. Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.
McDermott A; Kim N; Hausmann LRM; Magnani JW; Good CB; Litam TMA; Mor MK; Omole TD; Gellad WF; Fine MJ; Essien UR
J Gen Intern Med; 2023 Mar; 38(4):848-856. PubMed ID: 36151447
[TBL] [Abstract][Full Text] [Related]
2. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study.
Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ
J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154
[TBL] [Abstract][Full Text] [Related]
3. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
4. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
[TBL] [Abstract][Full Text] [Related]
6. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
7. Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation.
Omole TD; Zhu J; Garrard W; Thoma FW; Mulukutla S; McDermott A; Herbert BM; Essien UR; Magnani JW
Am J Prev Cardiol; 2022 Jun; 10():100346. PubMed ID: 35517873
[TBL] [Abstract][Full Text] [Related]
8. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
9. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.
Derington CG; Goodrich GK; Xu S; Clark NP; Reynolds K; An J; Witt DM; Smith DH; O'Keeffe-Rosetti M; Lang DT; Ho PM; Cheetham TC; Comer AC; King JB
JAMA Netw Open; 2023 Jul; 6(7):e2321971. PubMed ID: 37410461
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
[TBL] [Abstract][Full Text] [Related]
11. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
[TBL] [Abstract][Full Text] [Related]
12. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
[TBL] [Abstract][Full Text] [Related]
13. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
14. Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
Abdel-Qadir H; Akioyamen LE; Fang J; Pang A; Ha ACT; Jackevicius CA; Alter DA; Austin PC; Atzema CL; Bhatia RS; Booth GL; Johnston S; Dhalla I; Kapral MK; Krumholz HM; McNaughton CD; Roifman I; Tu K; Udell JA; Wijeysundera HC; Ko DT; Schull MJ; Lee DS
Circulation; 2022 Jul; 146(3):159-171. PubMed ID: 35678171
[TBL] [Abstract][Full Text] [Related]
15. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
16. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
[TBL] [Abstract][Full Text] [Related]
17. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
18. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
19. The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland.
Kennedy C; Gabr A; McCormack J; Collins R; Barry M; Harbison J
Br J Clin Pharmacol; 2022 Jan; 88(1):178-186. PubMed ID: 34131941
[TBL] [Abstract][Full Text] [Related]
20. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.
Polymeris AA; Meinel TR; Oehler H; Hölscher K; Zietz A; Scheitz JF; Nolte CH; Stretz C; Yaghi S; Stoll S; Wang R; Häusler KG; Hellwig S; Klammer MG; Litmeier S; Leon Guerrero CR; Moeini-Naghani I; Michel P; Strambo D; Salerno A; Bianco G; Cereda C; Uphaus T; Gröschel K; Katan M; Wegener S; Peters N; Engelter ST; Lyrer PA; Bonati LH; Grunder L; Ringleb PA; Fischer U; Kallmünzer B; Purrucker JC; Seiffge DJ
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):588-598. PubMed ID: 35396339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
